Belimumab

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Belimumab
Treatment and conditionWhere it standsTrials
Belimumab for lung diseases, interstitialPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Belimumab for scleroderma, diffusePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1